Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.
Identifieur interne : 002575 ( PubMed/Corpus ); précédent : 002574; suivant : 002576Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.
Auteurs : S L Harris ; M K Park ; M H Nahm ; B. DiamondSource :
- Infection and immunity [ 0019-9567 ] ; 2000.
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Antibodies, Anti-Idiotypic (immunology), Antibodies, Monoclonal (metabolism), Cattle, Cross Reactions, Immunization, Immunodominant Epitopes (immunology), Immunoglobulin G (biosynthesis), Mice, Mice, Inbred BALB C, Mice, Inbred CBA, Molecular Mimicry, Molecular Sequence Data, Opsonin Proteins, Peptides (chemistry), Peptides (immunology), Phosphorylcholine (chemistry), Phosphorylcholine (immunology), Phosphorylcholine (metabolism), Pneumococcal Infections (microbiology), Pneumococcal Infections (prevention & control), Serum Albumin, Bovine, Streptococcus pneumoniae (chemistry), Streptococcus pneumoniae (immunology), Vaccines, Conjugate.
- MESH :
- chemical , biosynthesis : Immunoglobulin G.
- chemical , chemistry : Peptides, Phosphorylcholine.
- chemical , immunology : Antibodies, Anti-Idiotypic, Immunodominant Epitopes, Peptides, Phosphorylcholine.
- chemical , metabolism : Antibodies, Monoclonal, Phosphorylcholine.
- chemistry : Streptococcus pneumoniae.
- immunology : Streptococcus pneumoniae.
- microbiology : Pneumococcal Infections.
- prevention & control : Pneumococcal Infections.
- Amino Acid Sequence, Animals, Cattle, Cross Reactions, Immunization, Mice, Mice, Inbred BALB C, Mice, Inbred CBA, Molecular Mimicry, Molecular Sequence Data, Opsonin Proteins, Serum Albumin, Bovine, Vaccines, Conjugate.
Abstract
Even in the age of antibiotics, Streptococcus pneumoniae causes significant morbidity, especially in the young, the elderly, and the immunocompromised. While a carbohydrate-based vaccine exists, it is poorly immunogenic in the at-risk populations. In mice, antibodies directed against phosphorylcholine (PC), an epitope present on the cell wall C polysaccharide of all pneumococcal serotypes, protect against infection. However, PC itself is a poor vaccine candidate. We report here peptide mimics of PC based on the anti-idiotypic interaction of T15 anti-PC antibodies. T15 antibodies, the dominant and protective idiotype induced in mice by PC immunization, self-associate via a 24-amino-acid region in the PC binding site (ASRNKANDYTTEYSASVKGRFIVS; peptide 1). Peptide 1 has been shown to bind in the PC binding site. We demonstrated that amino acid sequences derived from peptide 1 starting at amino acid 9, 11, or 13 inhibit PC binding. Therefore, we immunized mice with bovine serum albumin (BSA) conjugates of peptide 1 or either of two selected 12-mers. The 12-mer peptides were not immunogenic. Mice immunized with peptide 1-BSA developed an anti-PC response consisting mainly immunoglobulin G1 and expressed the T15 heavy chain. Nonetheless, neither BALB/c nor CBA/N mice were protected from lethal pneumococcal infections by immunization with peptide 1-BSA. Preliminary data suggest that peptide 1-BSA is not able to elicit the canonical T15 light chain, explaining the absence of protection. This idiotype-derived mimotope of PC is a useful tool for understanding immunologic cross-reactivity and learning to design T-cell-dependent vaccines for S. pneumoniae.
DOI: 10.1128/iai.68.10.5778-5784.2000
PubMed: 10992485
Links to Exploration step
pubmed:10992485Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.</title><author><name sortKey="Harris, S L" sort="Harris, S L" uniqKey="Harris S" first="S L" last="Harris">S L Harris</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Park, M K" sort="Park, M K" uniqKey="Park M" first="M K" last="Park">M K Park</name></author><author><name sortKey="Nahm, M H" sort="Nahm, M H" uniqKey="Nahm M" first="M H" last="Nahm">M H Nahm</name></author><author><name sortKey="Diamond, B" sort="Diamond, B" uniqKey="Diamond B" first="B" last="Diamond">B. Diamond</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2000">2000</date><idno type="RBID">pubmed:10992485</idno><idno type="pmid">10992485</idno><idno type="doi">10.1128/iai.68.10.5778-5784.2000</idno><idno type="wicri:Area/PubMed/Corpus">002575</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002575</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.</title><author><name sortKey="Harris, S L" sort="Harris, S L" uniqKey="Harris S" first="S L" last="Harris">S L Harris</name><affiliation><nlm:affiliation>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Park, M K" sort="Park, M K" uniqKey="Park M" first="M K" last="Park">M K Park</name></author><author><name sortKey="Nahm, M H" sort="Nahm, M H" uniqKey="Nahm M" first="M H" last="Nahm">M H Nahm</name></author><author><name sortKey="Diamond, B" sort="Diamond, B" uniqKey="Diamond B" first="B" last="Diamond">B. Diamond</name></author></analytic><series><title level="j">Infection and immunity</title><idno type="ISSN">0019-9567</idno><imprint><date when="2000" type="published">2000</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Antibodies, Anti-Idiotypic (immunology)</term><term>Antibodies, Monoclonal (metabolism)</term><term>Cattle</term><term>Cross Reactions</term><term>Immunization</term><term>Immunodominant Epitopes (immunology)</term><term>Immunoglobulin G (biosynthesis)</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Mice, Inbred CBA</term><term>Molecular Mimicry</term><term>Molecular Sequence Data</term><term>Opsonin Proteins</term><term>Peptides (chemistry)</term><term>Peptides (immunology)</term><term>Phosphorylcholine (chemistry)</term><term>Phosphorylcholine (immunology)</term><term>Phosphorylcholine (metabolism)</term><term>Pneumococcal Infections (microbiology)</term><term>Pneumococcal Infections (prevention & control)</term><term>Serum Albumin, Bovine</term><term>Streptococcus pneumoniae (chemistry)</term><term>Streptococcus pneumoniae (immunology)</term><term>Vaccines, Conjugate</term></keywords><keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Immunoglobulin G</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Peptides</term><term>Phosphorylcholine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Anti-Idiotypic</term><term>Immunodominant Epitopes</term><term>Peptides</term><term>Phosphorylcholine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antibodies, Monoclonal</term><term>Phosphorylcholine</term></keywords><keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Streptococcus pneumoniae</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pneumococcal Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Cattle</term><term>Cross Reactions</term><term>Immunization</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Mice, Inbred CBA</term><term>Molecular Mimicry</term><term>Molecular Sequence Data</term><term>Opsonin Proteins</term><term>Serum Albumin, Bovine</term><term>Vaccines, Conjugate</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Even in the age of antibiotics, Streptococcus pneumoniae causes significant morbidity, especially in the young, the elderly, and the immunocompromised. While a carbohydrate-based vaccine exists, it is poorly immunogenic in the at-risk populations. In mice, antibodies directed against phosphorylcholine (PC), an epitope present on the cell wall C polysaccharide of all pneumococcal serotypes, protect against infection. However, PC itself is a poor vaccine candidate. We report here peptide mimics of PC based on the anti-idiotypic interaction of T15 anti-PC antibodies. T15 antibodies, the dominant and protective idiotype induced in mice by PC immunization, self-associate via a 24-amino-acid region in the PC binding site (ASRNKANDYTTEYSASVKGRFIVS; peptide 1). Peptide 1 has been shown to bind in the PC binding site. We demonstrated that amino acid sequences derived from peptide 1 starting at amino acid 9, 11, or 13 inhibit PC binding. Therefore, we immunized mice with bovine serum albumin (BSA) conjugates of peptide 1 or either of two selected 12-mers. The 12-mer peptides were not immunogenic. Mice immunized with peptide 1-BSA developed an anti-PC response consisting mainly immunoglobulin G1 and expressed the T15 heavy chain. Nonetheless, neither BALB/c nor CBA/N mice were protected from lethal pneumococcal infections by immunization with peptide 1-BSA. Preliminary data suggest that peptide 1-BSA is not able to elicit the canonical T15 light chain, explaining the absence of protection. This idiotype-derived mimotope of PC is a useful tool for understanding immunologic cross-reactivity and learning to design T-cell-dependent vaccines for S. pneumoniae.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10992485</PMID><DateCompleted><Year>2000</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-9567</ISSN><JournalIssue CitedMedium="Print"><Volume>68</Volume><Issue>10</Issue><PubDate><Year>2000</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Infection and immunity</Title><ISOAbbreviation>Infect. Immun.</ISOAbbreviation></Journal><ArticleTitle>Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.</ArticleTitle><Pagination><MedlinePgn>5778-84</MedlinePgn></Pagination><Abstract><AbstractText>Even in the age of antibiotics, Streptococcus pneumoniae causes significant morbidity, especially in the young, the elderly, and the immunocompromised. While a carbohydrate-based vaccine exists, it is poorly immunogenic in the at-risk populations. In mice, antibodies directed against phosphorylcholine (PC), an epitope present on the cell wall C polysaccharide of all pneumococcal serotypes, protect against infection. However, PC itself is a poor vaccine candidate. We report here peptide mimics of PC based on the anti-idiotypic interaction of T15 anti-PC antibodies. T15 antibodies, the dominant and protective idiotype induced in mice by PC immunization, self-associate via a 24-amino-acid region in the PC binding site (ASRNKANDYTTEYSASVKGRFIVS; peptide 1). Peptide 1 has been shown to bind in the PC binding site. We demonstrated that amino acid sequences derived from peptide 1 starting at amino acid 9, 11, or 13 inhibit PC binding. Therefore, we immunized mice with bovine serum albumin (BSA) conjugates of peptide 1 or either of two selected 12-mers. The 12-mer peptides were not immunogenic. Mice immunized with peptide 1-BSA developed an anti-PC response consisting mainly immunoglobulin G1 and expressed the T15 heavy chain. Nonetheless, neither BALB/c nor CBA/N mice were protected from lethal pneumococcal infections by immunization with peptide 1-BSA. Preliminary data suggest that peptide 1-BSA is not able to elicit the canonical T15 light chain, explaining the absence of protection. This idiotype-derived mimotope of PC is a useful tool for understanding immunologic cross-reactivity and learning to design T-cell-dependent vaccines for S. pneumoniae.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>S L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>M K</ForeName><Initials>MK</Initials></Author><Author ValidYN="Y"><LastName>Nahm</LastName><ForeName>M H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Diamond</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI031473</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AI031473</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI31473</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AI42997</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Infect Immun</MedlineTA><NlmUniqueID>0246127</NlmUniqueID><ISSNLinking>0019-9567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000888">Antibodies, Anti-Idiotypic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016056">Immunodominant Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009895">Opsonin Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018074">Vaccines, Conjugate</NameOfSubstance></Chemical><Chemical><RegistryNumber>107-73-3</RegistryNumber><NameOfSubstance UI="D010767">Phosphorylcholine</NameOfSubstance></Chemical><Chemical><RegistryNumber>27432CM55Q</RegistryNumber><NameOfSubstance UI="D012710">Serum Albumin, Bovine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000888" MajorTopicYN="N">Antibodies, Anti-Idiotypic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016056" MajorTopicYN="N">Immunodominant Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008808" MajorTopicYN="N">Mice, Inbred CBA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018716" MajorTopicYN="Y">Molecular Mimicry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009895" MajorTopicYN="N">Opsonin Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010767" MajorTopicYN="N">Phosphorylcholine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012710" MajorTopicYN="N">Serum Albumin, Bovine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013296" MajorTopicYN="N">Streptococcus pneumoniae</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018074" MajorTopicYN="N">Vaccines, Conjugate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year><Month>9</Month><Day>19</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>2</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2000</Year><Month>9</Month><Day>19</Day><Hour>11</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10992485</ArticleId><ArticleId IdType="pmc">PMC101537</ArticleId><ArticleId IdType="doi">10.1128/iai.68.10.5778-5784.2000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1978 May;75(5):2458-62</Citation><ArticleIdList><ArticleId IdType="pubmed">276884</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1977 Oct;7(10):749-51</Citation><ArticleIdList><ArticleId IdType="pubmed">338312</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1980 Jul 1;152(1):209-18</Citation><ArticleIdList><ArticleId IdType="pubmed">6156981</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 1980 Sep 30;19(20):4712-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7426624</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1981 Mar 1;153(3):694-705</Citation><ArticleIdList><ArticleId IdType="pubmed">7252411</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1981 Nov 1;154(5):1584-98</Citation><ArticleIdList><ArticleId IdType="pubmed">7299349</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1982 Oct 1;156(4):1177-85</Citation><ArticleIdList><ArticleId IdType="pubmed">7153709</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1988 May 20;240(4855):1034-6</Citation><ArticleIdList><ArticleId IdType="pubmed">3368787</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Microbiol. 1989 Apr;28(4):237-48</Citation><ArticleIdList><ArticleId IdType="pubmed">2649678</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Cell Immunol. 1984;1(5):305-9</Citation><ArticleIdList><ArticleId IdType="pubmed">6336560</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1992 Feb;14(2):427-35</Citation><ArticleIdList><ArticleId IdType="pubmed">1554828</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1992 Dec 1;176(6):1637-43</Citation><ArticleIdList><ArticleId IdType="pubmed">1460422</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1993 Jan 15;150(2):543-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8419487</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol Immunopathol. 1993 Feb;66(2):176-80</Citation><ArticleIdList><ArticleId IdType="pubmed">8453788</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene. 1993 Jun 15;128(1):43-9</Citation><ArticleIdList><ArticleId IdType="pubmed">7685300</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1994 Jun 15;271(23):1831-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8196139</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1995 Feb 15;154(4):1810-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7836766</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):4021-5</Citation><ArticleIdList><ArticleId IdType="pubmed">7732025</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1995 Jul 15;155(2):967-73</Citation><ArticleIdList><ArticleId IdType="pubmed">7608572</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1996 Apr 1;183(4):1905-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8666947</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1996 Aug 9;261(1):11-22</Citation><ArticleIdList><ArticleId IdType="pubmed">8760499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1997 Feb 17;185(4):685-94</Citation><ArticleIdList><ArticleId IdType="pubmed">9034147</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2454-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9122216</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Immunol. 1997 May;9(5):665-77</Citation><ArticleIdList><ArticleId IdType="pubmed">9184912</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 1997 Oct;27(10):2620-5</Citation><ArticleIdList><ArticleId IdType="pubmed">9368618</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1997 Dec 12;274(4):622-34</Citation><ArticleIdList><ArticleId IdType="pubmed">9417940</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1998 Feb 16;187(4):641-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9463414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1998 Feb 7;351(9100):399-403</Citation><ArticleIdList><ArticleId IdType="pubmed">9482293</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 1998 Mar;66(3):1057-62</Citation><ArticleIdList><ArticleId IdType="pubmed">9488395</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1998 Jan 1;160(1):293-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9551983</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1998 Aug 15;161(4):1829-36</Citation><ArticleIdList><ArticleId IdType="pubmed">9712050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hybridoma. 1999 Apr;18(2):121-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10380011</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Recognit. 1999 May-Jun;12(3):191-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10398409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 1999 Apr;36(6):339-47</Citation><ArticleIdList><ArticleId IdType="pubmed">10443998</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1983 Feb 24;301(5902):720-2</Citation><ArticleIdList><ArticleId IdType="pubmed">6186921</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1983 Jun;130(6):2871-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6854020</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1983 Dec;148(6):1136-59</Citation><ArticleIdList><ArticleId IdType="pubmed">6361173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Immunol. 1984 Oct;21(10):961-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6209566</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1984 Dec 14;226(4680):1325-6</Citation><ArticleIdList><ArticleId IdType="pubmed">6505692</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1987 Jan 8-14;325(7000):168-71</Citation><ArticleIdList><ArticleId IdType="pubmed">3808074</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1987 May 1;165(5):1332-43</Citation><ArticleIdList><ArticleId IdType="pubmed">3106554</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1987 Oct;25(10):1854-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3499450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1988 Apr 15;140(8):2675-80</Citation><ArticleIdList><ArticleId IdType="pubmed">3128603</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 1999 Nov 19;294(1):181-91</Citation><ArticleIdList><ArticleId IdType="pubmed">10556037</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Immunol Med Microbiol. 1999 Dec;26(3-4):209-26</Citation><ArticleIdList><ArticleId IdType="pubmed">10575132</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2000 Jan 18;18(13):1253-63</Citation><ArticleIdList><ArticleId IdType="pubmed">10649627</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochemistry. 1972 Feb 29;11(5):766-71</Citation><ArticleIdList><ArticleId IdType="pubmed">5059886</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1974 Jan 1;139(1):58-73</Citation><ArticleIdList><ArticleId IdType="pubmed">4128448</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1974 Jan 4;247(5435):55-7</Citation><ArticleIdList><ArticleId IdType="pubmed">4128785</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1977 Oct 1;146(4):1138-42</Citation><ArticleIdList><ArticleId IdType="pubmed">302313</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1979 Dec;140(6):979-83</Citation><ArticleIdList><ArticleId IdType="pubmed">44310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002575 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002575 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:10992485
|texte= Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:10992485" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |